Medicine changes lives.
Research changes the world.
Every day, Mass General Brigham scientists chart new terrain in biomedical research to prevent and treat human disease and advance patient care — locally and across the globe.
Recent News
Gatchel Untangles the Causes of Mood and Anxiety Symptoms and Loss of Brain Function in Aging Populations
Mass General geriatric psychiatrist Jennifer Gatchel MD, PhD, is working to unravel the connections between mental illness and the onset of Alzheimer’s disease.
Study Predicts Alzheimer’s Cases to Double in US by 2060. How Mass General Researchers are Fighting Back.
Scientists at the National Institutes of Health (NIH) released some unsettling new estimates about the number of individuals affected with Alzheimer’s disease this week—and how that number is expected to skyrocket in the near future.
Proteins Take Shape with New Technology
The 2017 Nobel Prize in Chemistry went to three scientists for their development of a new technology called cryo-electron microscopy (cryo-EM). This technique freezes proteins, and bombards them with electrons, allowing researchers to observe the building blocks of human cells. In a recent podcast by Proto, Luke Chao, PhD, a researcher in the department of molecular…
Four Mass General Investigators Recognized with Endowed Chairs
Massachusetts General Hospital recently established four endowed chairs. Meet the investigators whose work and contributions have been recognized through their appointment to these roles and please join us in congratulating them!
World AIDS Day 2017
World AIDS Day takes place on the 1st of December each year. It’s an opportunity to highlight the success of worldwide efforts to combat HIV/AIDS, as well as the importance of continued support for these efforts.
New Screening Technique Makes Waves in Quest for Earlier Diagnosis of Alzheimer’s Disease
How could the study of patients under anesthesia lead to a new way to diagnose Alzheimer’s disease? It could all come down to brainwaves.
Harvard Catalyst – A Great Resource for Researchers
Established in 2008, Harvard Catalyst | The Harvard Clinical and Translational Science Center is dedicated to improving human health by enabling collaboration and providing tools, training, and technologies to clinical and translational investigators.
Study Identifies New Targets for Huntington’s Disease Research
Huntington’s disease (HD) is a fatal genetic disorder that causes the progressive breakdown of nerve cells in the brain.
Celebrity Patients Bring Lupus into The Headlines, But Much Remains Unknown
This September, actress and singer Selena Gomez announced on Instagram that she underwent a kidney transplant as part of her treatment for lupus, an autoimmune disease in which a body’s immune system begins to attack its own tissues and organs.
Investigators Add New Insights to Lyme Disease Diagnosis and Treatment
With the number of reported Lyme disease infections on the rise, Massachusetts General Hospital researchers are helping to meet the need for new diagnostic tools and treatments.